| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Edward M Basile is Director at TMDX. Edward M Basile's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $390K at current prices.
Historically, Edward M Basile's trades have earned a middling insider score of 67/100 across 11 rated trades. Over a 12-month horizon, 63.6% of those trades were profitable, with an average 12-month return of +15.4%.
The TMDX filings lean toward selling, a net 48,292 shares.
Edward M Basile has 19 Form 4 filings on record from May 2019 to May 2026, all as Director at TransMedics Group (TMDX), 2019–2026.
The 41 reported transactions were 22 open-market sales, 6 option exercises, 5 option or other derivative awards and 4 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $136K and 11 sales worth about $6.3M.
The only open-market purchase was 8,500 shares of TMDX at an average $16.00 on May 6, 2019, about $136K.
The largest open-market sale was 6,750 shares of TMDX at an average $149.96 on August 6, 2024, about $1.0M. Twelve months later TMDX was down 24%.
8 of the 9 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 4,142 | $130.45 | $540,323.90 | -59.1% | +3.1% | -50.0% | |
| Aug 4, 2025 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 4,143 | $125.51 | $519,987.93 | -59.1% | -2.9% | -37.2% | |
| May 27, 2025 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 5,000 | $126.45 | $632,250.00 | -63.6% | -10.6% | -45.4% | |
| May 9, 2025 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 6,000 | $115.63 | $693,780.00 | -89.1% | +4.1% | -39.2% | |
| Nov 5, 2024 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 6,750 | $83.55 | $563,993.80 | -90.2% | -17.2% | +50.0% | |
| Aug 6, 2024 | TMDX Transmedics Group, Inc. | Director | Sale+OE10b5-1 | 6,750 | $149.96 | $1,012,229.66 | -90.2% | -45.6% | -23.9% | |
| Jun 5, 2024 | TMDX Transmedics Group, Inc. | Director | Sell | 1,193 | $138.08 | $164,729.44 | -62.0% | +18.0% | +0.4% | |
| May 7, 2024 | TMDX Transmedics Group, Inc. | Director | Sell10b5-1 | 7,157 | $129.98 | $930,278.49 | -85.7% | +16.6% | -24.7% | |
| Feb 6, 2024 | TMDX Transmedics Group, Inc. | Director | Sell10b5-1 | 7,157 | $86.38 | $618,209.43 | -46.2% | +53.0% | -14.0% | |
| Mar 1, 2023 | TMDX Transmedics Group, Inc. | Director | Sell | 3,500 | $80.10 | $280,350.00 | -19.6% | -11.1% | +0.3% |